NOS2 and cancer: Inducible nitric oxide synthase (iNOS) is a central enzymatic source of high-output nitric oxide (NO) in innate and adaptive immunity, where dysregulated NO contributes to chronic inflammation, metabolic and cardiovascular disorders, and cancer [1–4].